Isabella Berry

Pronouns: she/they

Languages: English, Spanish

​

Isabella Berry has loved science and research since as early as 7th grade when she was mentored at her local college university in cellular and molecular biology and conducted research on quercetin as a treatment for B16 melanoma and was published on that paper. Her experience with mentorship at an early age inspired her to continue pursuing academia and research throughout her life. 

 

Throughout high school she stayed involved in research doing student needs assessments for her high school counseling team, developing mental health curriculum for military affiliated students, and also participating in the Research Science Institute during 2022 at MIT and Tufts Medical Center where she conducted research on the viability of normoxemic ECMO in the Kapur lab. 

 

Due to her access to research and opportunity, she has had the opportunity to explore various areas of medicine including cancer biology, psychology, interventional cardiology and neuropharmacology. 

 

She is an undergraduate student at the University of Michigan studying biochemistry and biophysics with a minor in mathematics. She currently researches in the Jenkins lab in neuropharmacology, studying the relationship between ankyrin proteins and voltage gated sodium ion channels for autism spectrum disorder and bipolar disorder. Following her diagnosis with mental health disorders, Isabella continued her work in mental health advocacy in academia and pursued research opportunities in neuropharmacology. Outside of her goals of improving treatments for patients with mental health disorders, Isabella wants to afford everyone the opportunities she has been fortunate to have and improve research access to underrepresented groups. 

​

Awards and Honors

Research Science Institute Scholar, August 2022

​

Selected Works

Soll, F., Ternent, C., Berry, I. M., Kumari, D., & Moore, T. C. (2020). Quercetin Inhibits Proliferation and Induces Apoptosis of B16 Melanoma Cells In Vitro. Assay and drug development technologies, 18(6), 261–268. https://doi.org/10.1089/adt.2020.993